Login / Signup

Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study.

Ghobad MalekiAhnjili ZhuparrisIngrid W KoopmansRobert-Jan DollNicoline B M VoetAdam A CohenEmilie M J van BrummelenGeert Jan GroeneveldJoris H De Maeyer
Published in: JMIR formative research (2022)
ClinicalTrials.gov NCT04999735; https://www.clinicaltrials.gov/ct2/show/NCT04999735.
Keyphrases
  • clinical trial
  • muscular dystrophy
  • image quality
  • computed tomography
  • dual energy
  • contrast enhanced
  • early onset
  • phase ii
  • positron emission tomography
  • randomized controlled trial
  • open label
  • phase iii
  • double blind